Autres langues Simulations Plus, Inc.

Actions

SLP

US8292141053

Equipement et technologie médicale avancés

Marché Fermé - Nasdaq 22:00:00 18/09/2026			Varia. 5j.	Varia. 1 janv.
18,44 ^USD	0,00%		+0,11%	+1,15%

18/09	Simulations Plus annonce l'adoption d'ADMET Predictor par la division cosmétique de la FDA	MT
17/09	Simulations Plus, Inc. étend l'adoption d'ADMET Predictor par la FDA avec de nouvelles licences pour la branche des sciences réglementaires des cosmétiques	CI

Autres langues

18/09	Simulations Plus Expands FDA Adoption of ADMET Predictor(R) with New Licenses for the Cosmetics Regulatory Science Branch
18/09	Simulations Plus Says FDA's Cosmetics Branch Adopts ADMET Predictor
17/09	Simulations Plus Expands FDA Adoption of ADMET Predictor® with New Licenses for the Cosmetics Regulatory Science Branch
17/09	Simulations Plus, Inc. Expands FDA Adoption Of ADMET Predictor With New Licenses For The Cosmetics Regulatory Science Branch
16/09	Pharma sector doubles down on AI to slash costs, timelines
20/08	Pharma sector doubles down on AI amid hopes of slashing costs, timelines
13/08	Simulations Plus Announces Expiration of Hart-Scott-Rodino Waiting Period for Pending Acquisition by Altaris
30/07	Simulations Plus Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Simulations Plus, Inc. - SLP
09/07	Simulations Plus: Fiscal Q3 Earnings Snapshot
09/07	Simulations Plus Fiscal Q3 Adjusted Earnings Decline, Revenue Rises
09/07	Tranche Update on Simulations Plus, Inc.'s Equity Buyback Plan announced on January 4, 2023.
09/07	Simulations Plus, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended May 31, 2026
09/07	Simulations Plus Reports Third Quarter Fiscal 2026 Financial Results
06/07	Johnson Fistel Investigates Simulations Plus Following Revenue Guidance Cut and Accounting Disclosures
29/06	Simulations Plus, Inc.(NasdaqGS:SLP) added to Russell Microcap Value Benchmark Index
29/06	Simulations Plus, Inc.(NasdaqGS:SLP) added to Russell 2000 Value Benchmark
29/06	Simulations Plus, Inc.(NasdaqGS:SLP) dropped from Russell 2000 Growth-Defensive Index
29/06	Simulations Plus, Inc.(NasdaqGS:SLP) dropped from Russell 2000 Defensive Index
29/06	Simulations Plus, Inc.(NasdaqGS:SLP) added to Russell 3000E Value Benchmark
29/06	Simulations Plus, Inc.(NasdaqGS:SLP) added to Russell 3000 Value Benchmark
29/06	Simulations Plus, Inc.(NasdaqGS:SLP) added to Russell Small Cap Comp Value Benchmark
29/06	Simulations Plus, Inc.(NasdaqGS:SLP) added to Russell 2500 Value Benchmark
23/06	Simulations Plus Advances Agentic Drug Development with NVIDIA BioNeMo Agent Toolkit
22/06	Simulations Plus (SLP) Investigation: Investors Who Suffered Losses Encouraged to Contact Johnson Fistel
18/06	Simulations Plus Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Simulations Plus, Inc. - SLP